PI 3-kinase C2α (17) Antibody sc-136298 from Santa Cruz Biotechnology, Inc.

Product Specs
ItemPI 3-kinase C2α (17) Antibody
CompanySanta Cruz Biotechnology, Inc.
Price $316.00Supplier Page View Company Product Page
Catalog Numbersc-136298
ApplicationsWB, IP, IF
Hostmouse
NCBI Gene AliasesOCSKD, CPK, PI3-K-C2(ALPHA), PI3K-C2-alpha, PI3KC2, PI3K-C2alpha, Cpk-m, PI3-K-C2A
Quantity50 µg/0.5 ml
Clone17
Conjugate/TagUnconjugated
Reactivitymouse, rat, human
FormatPurified
ClonalityMonoclonal
Antibody TypePrimary Antibodies
NCBI Full Gene Namephosphatidylinositol-4-phosphate 3-kinase catalytic subunit type 2 alpha
TargetPI 3-kinase C2alpha
IsotypeIgG1

Add to Compare List

Santa Cruz Biotechnology, Inc.

10410 Finnell Street

Dallas, Texas 75220

United States

Phone: 1-800-457-3801
831-457-3801

Company Profile

Website: http://www.scbt.com/

(1) Long non-coding RNA GASL1 inhibits proliferation and invasion of osteosarcoma cells via modulation of the PI3K/Akt pathwayArchives of medical science : AMSJanuary 1, 2023Gao F, Xu F.performed using primary Akt (cat. no.sc-135829), phosphorylated (p)-AKT (cat. no. sc-7985-R), PI3K (cat. no.sc-136298) (all 1 : 1,000; all Santa Cruz Biotechnology, Inc., Dallas, TX, USA) and secondary antibodies (horseradish

(2) High expression of ubiquitin carboxyl-terminal hydrolase 22 is associated with poor prognosis in hepatitis B virus-associated liver cancerOncology lettersJune 1, 2019Liao Y, Liang X, Liang W, Li Z, Wang Y, Wang L, Zhen S, Tang B, Wang Z.(abcam2324, concentration is 1:1,000). The primary antibodies of phosphoinositide 3‑kinase (PI3K) (SC‑136298), phosphorylated (p)‑PI3K (Cat. No. 20584‑1‑AP), protein kinase B (Akt) (SC‑135829) and p‑Akt (SC‑271964)

(3) Mahanine induces apoptosis, cell cycle arrest, inhibition of cell migration, invasion and PI3K/AKT/mTOR signalling pathway in glioma cells and inhibits tumor growth in vivoChemico-biological interactionsFebruary 1, 2019Chen M, Yin X, Lu C, Chen X, Ba H, Cai J, Sun J.

(4) miR-140-3p Suppresses Cell Growth And Induces Apoptosis In Colorectal Cancer By Targeting PD-L1OncoTargets and therapyJanuary 1, 2019Jiang W, Li T, Wang J, Jiao R, Shi X, Huang X, Ji G.follows: anti-PD-L1 (Cell Signaling Technology, 3127S), anti-PI3K (Santa Cruz Biotechnologies cat.no. sc-136298), anti-p-PI3K (Cell Signaling Technology, cat. no. 4228), anti-AKT (Cell Signaling Technology, 4691S),

(5) Inactivation of P2YR12 contributes to isoflurane-induced neuronal injury by altering TLR-4/BDNF/TNF-αFolia neuropathologicaJanuary 1, 2019Sun N, Chu L, Yuan L, Qi Z.filtered onto a nitrocellulose membrane. The membrane was incubated with Iry antibodies, including PI3K (sc-136298; Santa Cruz Biotechnology, Santa Cruz CA, USA), Akt (sc-24500; Santa Cruz), Bcl-2 (sc-509; Santa Cruz),

(6) Sorghumol triterpene inhibits the growth of circulating renal cancer cells by promoting cell apoptosis, G2/M cell cycle arrest and downregulating m-TOR/PI3K/AKT signalling pathwayJournal of B.U.ON. : official journal of the Balkan Union of OncologyJanuary 1, 2019Li H, Dan C, Gong X, Zeng W, Yao Q, Yang Y, Gong X, Wang L, Chen C, Huang L.

(7) Quantitative Lipid Imaging Reveals a New Signaling Function of Phosphatidylinositol-3,4-Bisphophate: Isoform- and Site-Specific Activation of AktMolecular cellSeptember 20, 2018Liu SL, Wang ZG, Hu Y, Xin Y, Singaram I, Gorai S, Zhou X, Shim Y, Min JH, Gong LW, et al.

(8) Anticancer activity of caffeic acid n‑butyl ester against A431 skin carcinoma cell line occurs via induction of apoptosis and inhibition of the mTOR/PI3K/AKT signaling pathwayMolecular medicine reportsApril 1, 2018Zeng N, Hongbo T, Xu Y, Wu M, Wu Y.

(9) Anticancer activity of 23,24-dihydrocucurbitacin B against the HeLa human cervical cell line is due to apoptosis and G(2)/M cell cycle arrestExperimental and therapeutic medicineMarch 1, 2018Zhang JX, Wei-Tan H, Hu CY, Wang WQ, Chu GH, Wei LH, Chen L.no. sc‑58673), Akt (cat. no. sc‑135829), phosphorylated (p)‑AKT (cat. no. sc‑7985‑R), P13K (cat. no. sc‑136298), p‑P13K (cat. no. sc‑100407), mTOR (cat. no. sc‑517464) and p‑mTOR (cat. no. sc‑293133; all 1:1,000).

(10) MiR-144-3p inhibits cell proliferation and induces apoptosis in multiple myeloma by targeting c-MetAmerican journal of translational researchJanuary 1, 2017Zhao Y, Xie Z, Lin J, Liu P.

(11) miR-124 regulates fetal pulmonary epithelial cell maturationAmerican journal of physiology. Lung cellular and molecular physiologyAugust 15, 2015Wang Y, Huang C, Chintagari NR, Xi D, Weng T, Liu L.monoclonal anti-PIK3C2A (phosphatidylinositol-4-phosphate 3-kinase, catalytic subunit type 2 alpha; sc-136298; 1:200; Santa Cruz Biotechnology, Santa Cruz, CA), rabbit polyclonal anti-son of sevenless homolog 1

(12) GDF15 alleviates the progression of benign tracheobronchial stenosis by inhibiting epithelial-mesenchymal transition and inactivating fibroblastsExperimental cell researchJanuary 1, 0001"Liao J, Gan Y, Peng M, Giri M, Yang S, Gu L, Li A, Xiao R, He C, Li Y, et al."

Be the First to Write a Review!

PI 3-kinase C2α (17) Antibody

PI 3-kinase C2α (17) Antibody from Santa Cruz Biotechnology, Inc.

Description

Santa Cruz Biotechnology, Inc.

Citations (12)

Reviews

PI 3-kinase C2α (17) Antibody from Santa Cruz Biotechnology, Inc.

About Biocompare

Advertise with Us

Specialized Search Tools

Site Map